Tiziana Life Sciences back under the spotlight ... the series returns!

Punters might want to keep an eye on Tiziana Life Sciences, the London-listed biopharmaceutical company.

That's because Betaville hears the company has been working on a Covid-19 drug treatment that might be able to address the new variants of the virus entering the United Kingdom...

Register

Register for free to see rest of this article and all public articles from Betaville

Login / Register
Date: Tuesday, 2 February 2021, 6:49 am

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation